Below is the information that is necessary to complete your abstract submission. You will be able to start an abstract, then save and finish later, should you need to do so. I. Title of Abstract - Please use Title case. II. Abstract Categories a. Outcome Measures (Quality of life and clinical trials, and patient registries) b. Basic Science (Melanocyte biology- e.g. keratinocyte/fibroblasts defects, growth factors, oxidative stress) c. Medical Treatment (topical, phototherapy, systemic) d. Epidemiology/nomenclature/classification, clinical characteristics, DDX, and prognostic factors III. Authors IV. Body a. Introduction - This should give background regarding the topic that you are writing about. This may include what prompted this study and what you are examining, studying or reporting. b. Objective - This should be a statement explaining what you sought to establish, measure, observe or prove. c. Materials and/or Methods ¬- This should include how you carried out your study, what you examined and how you measured or analyzed the material or data. If your abstract is accepted, and you are selected to present you must disclose the methodology used to calculate all rates. d. Discussion/Results - This should include what your analysis revealed and what it might lead to. Final data must be submitted. Only under extenuating circumstances will preliminary data be acceptable. Please indicate the reason if this is the case. e. Conclusion - Summarize what you proved or disproved. Include patient recommendations, if any. All patient recommendations involving clinical medicine will be based on evidence that is accepted within the profession of medicine as adequate justification for their indications or contraindications in the care of patients. All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. If you refer to research that does not meet the generally accepted standards as described above, then you should indicate this and disclose that the patient recommendations are anecdotal. V. Take Home Message ¬- State the main point you would like the audience to take away from your presentation/poster (Max. 150 words) VI. Disclosures - Please disclose relevant commercial relationships and off-label usage as well as author release information. If you do not have anything to disclose, you must indicate this within this field. Disclosure information for all authors is required upon abstract submission. VII. Is this an encore presentation?Below is the information that is necessary to complete your abstract submission. You will be able to start an abstract, then save and finish later, should you need to do so. I. Title of Abstract - Please use Title case. II. Abstract Categories a. Outcome Measures (Quality of life and clinical trials, and patient registries) b. Basic Science (Melanocyte biology- e.g. keratinocyte/fibroblasts defects, growth factors, oxidative stress) c. Medical Treatment (topical, phototherapy, systemic) d. Epidemiology/nomenclature/classification, clinical characteristics, DDX, and prognostic factors III. Authors IV. Body a. Introduction - This should give background regarding the topic that you are writing about. This may include what prompted this study and what you are examining, studying or reporting. b. Objective - This should be a statement explaining what you sought to establish, measure, observe or prove. c. Materials and/or Methods ¬- This should include how you carried out your study, what you examined and how you measured or analyzed the material or data. If your abstract is accepted, and you are selected to present you must disclose the methodology used to calculate all rates. d. Discussion/Results - This should include what your analysis revealed and what it might lead to. Final data must be submitted. Only under extenuating circumstances will preliminary data be acceptable. Please indicate the reason if this is the case. e. Conclusion - Summarize what you proved or disproved. Include patient recommendations, if any. All patient recommendations involving clinical medicine will be based on evidence that is accepted within the profession of medicine as adequate justification for their indications or contraindications in the care of patients. All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. If you refer to research that does not meet the generally accepted standards as described above, then you should indicate this and disclose that the patient recommendations are anecdotal. V. Take Home Message ¬- State the main point you would like the audience to take away from your presentation/poster (Max. 150 words) VI. Disclosures - Please disclose relevant commercial relationships and off-label usage as well as author release information. If you do not have anything to disclose, you must indicate this within this field. Disclosure information for all authors is required upon abstract submission. VII. Is this an encore presentation?